Document is current
Any future updates will be listed below
-
Authors
Nayeri, Zahra
Tavakol, Elahe
Rahmati, Marveh
Cordani, Marco
Djavaheri-Mergny, Mojgan
Shariati, Vahid
Moosavi, Mohammad Amin
-
Funding
Funding for this research was provided by:
Tehran University of Medical Sciences
Ministerio de Ciencia, Innovación y Universidades (RYC2021–031003I)
Institut National de la Santé et de la Recherche Médicale
Agence Nationale de la Recherche (ANR-21-CE44-0016 (CISCO))
Institut National Du Cancer (INCa (PLBIO23-216-2023-181))
National Institute of Genetic Engineering and Biotechnology (900)
- License Information
-
More Information
Article History
Received: 21 July 2025
Accepted: 19 November 2025
First Online: 25 November 2025
Declarations
:
: The data used in our study were obtained from the TCGA public database; therefore, ethical approval was not required.
: Marco Cordani has received honoraria and consultancy contracts from EQA Certificados and OCA Global. These activities are unrelated to the present study and did not influence its content or conclusions. Marco Cordani also declares that he is an Editorial Board Member of Discover Oncology and confirms that he had no role in the handling or decision-making process for his own submission. The remaining authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
